Targeted hyperthermia using metal nanoparticles

Advanced Drug Delivery Reviews

Volumn 62, Issue 3, 2010, Pages 339-345

  Cherukuri, Paul ^a,b,c   Glazer, Evan S ^a   Curley, Steven A ^a,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RICE UNIVERSITY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Rice University   (United States)

Author keywords

Inorganic nanoparticles; Radiofrequency; Thermal therapy

Indexed keywords

CLINICAL TRIAL; INORGANIC NANOPARTICLE; MALIGNANT CELLS; METAL NANOPARTICLES; NEAR-INFRARED RADIATIONS; PRE-CLINICAL; RADIO FREQUENCIES; RADIO-FREQUENCY ABLATION; RADIO-FREQUENCY FIELDS; THERMAL THERAPIES;

INFRARED RADIATION;

NANOPARTICLES;

BEVACIZUMAB; BORTEZOMIB; CARBON NANOTUBE; CELL PENETRATING PEPTIDE; GEFITINIB; GOLD NANOPARTICLE; IMATINIB; METAL NANOPARTICLE; NANOMATERIAL; RITUXIMAB; SINGLE WALLED NANOTUBE; SORAFENIB; TAMOXIFEN; TAMOXIFEN CITRATE; TOSITUMOMAB; TOSITUMOMAB I 131; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; CELL DEATH; CYTOTOXICITY; HEATING; HUMAN; HYPERTHERMIA; IONIZING RADIATION; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; NANOTECHNOLOGY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW;

CATHETER ABLATION; CLINICAL TRIALS AS TOPIC; GOLD; HUMANS; HYPERTHERMIA, INDUCED; METAL NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 76749116607     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.11.006     Document Type: Review

References (59)

1. Link S., and El-Sayed M.A. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu. Rev. Phys. Chem. 54 (2003) 331-366
2. Hartman K.B., Wilson L.J., and Rosenblum M.G. Detecting and treating cancer with nanotechnology. Mol. Diagn. Ther. 12 (2008) 1-14
3. Sumer B., and Gao J. Theranostic nanomedicine for cancer. Nanomedicine 3 (2008) 137-140
4. Cho K., Wang X., Nie S., Chen Z.G., and Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14 (2008) 1310-1316
5. Hartman K.B., and Wilson L.J. Carbon nanostructures as a new high-performance platform for MR molecular imaging. Adv. Exp. Med. Biol. 620 (2007) 74-84
6. Wang A., and Li S. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. BMC Biotechnol. 8 (2008) 46
7. Li S., Wang A., Jiang W., and Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer 8 (2008) 103
8. Hwang H.Y., Kim I.S., Kwon I.C., and Kim Y.H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 128 (2008) 23-31
9. Patra C.R., Bhattacharya R., Wang E., Katarya A., Lau J.S., Dutta S., Muders M., Wang S., Buhrow S.A., Safgren S.L., Yaszemski M.J., Reid J.M., Ames M.M., Mukherjee P., and Mukhopadhyay D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 68 (2008) 1970-1978
10. Visaria R.K., Griffin R.J., Williams B.W., Ebbini E.S., Paciotti G.F., Song C.W., and Bischof J.C. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol. Cancer Ther. 5 (2006) 1014-1020
11. Farma J.M., Puhlmann M., Soriano P.A., Cox D., Paciotti G.F., Tamarkin L., and Alexander H.R. Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor. Int. J. Cancer 120 (2007) 2474-2480
12. Richard C., de Chermont Qle M., and Scherman D. Nanoparticles for imaging and tumor gene delivery. Tumori 94 (2008) 264-270
13. Opanasopit P., Apirakaramwong A., Ngawhirunpat T., Rojanarata T., and Ruktanonchai U. Development and characterization of pectinate micro/nanoparticles for gene delivery. AAPS PharmSciTech 9 (2008) 67-74
14. Kam N.W., Liu Z., and Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew. Chem. Int. Ed. Engl. 45 (2006) 577-581
15. Chang M.Y., Shiau A.L., Chen Y.H., Chang C.J., Chen H.H., and Wu C.L. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 99 (2008) 1479-1484
16. Mukherjee P., Bhattacharya R., Bone N., Lee Y.K., Patra C.R., Wang S., Lu L., Secreto C., Banerjee P.C., Yaszemski M.J., Kay N.E., and Mukhopadhyay D. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J. Nanobiotechnol. 5 (2007) 4
17. Mukherjee P., Bhattacharya R., Wang P., Wang L., Basu S., Nagy J.A., Atala A., Mukhopadhyay D., and Soker S. Antiangiogenic properties of gold nanoparticles. Clin. Cancer Res. 11 (2005) 3530-3534
18. Kou G., Wang S., Cheng C., Gao J., Li B., Wang H., Qian W., Hou S., Zhang D., Dai J., Gu H., and Guo Y. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection. Biochem. Biophys. Res. Commun. 374 (2008) 192-197
19. Barcena C., Sra A.K., Chaubey G.S., Khemtong C., Liu J.P., and Gao J. Zinc ferrite nanoparticles as MRI contrast agents. Chem. Commun. (Camb.) (2008) 2224-2226
20. Neumaier C.E., Baio G., Ferrini S., Corte G., and Daga A. MR and iron magnetic nanoparticles. Imaging opportunities in preclinical and translational research. Tumori 94 (2008) 226-233
21. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., Chen X., and Dai H. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2 (2007) 47-52
22. Matson J.B., and Grubbs R.H. Synthesis of fluorine-18 functionalized nanoparticles for use as in vivo molecular imaging agents. J. Am. Chem. Soc. 130 (2008) 6731-6733
23. Zhang H., Yee D., and Wang C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine 3 (2008) 83-91
24. Misra R.D. Quantum dots for tumor-targeted drug delivery and cell imaging. Nanomedicine 3 (2008) 271-274
25. Curry A.C., Crow M., and Wax A. Molecular imaging of epidermal growth factor receptor in live cells with refractive index sensitivity using dark-field microspectroscopy and immunotargeted nanoparticles. J. Biomed. Opt. 13 (2008) 014022
26. Kelly K.A., Setlur S.R., Ross R., Anbazhagan R., Waterman P., Rubin M.A., and Weissleder R. Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res. 68 (2008) 2286-2291
27. Wu J., Yan F., Zhang X., Yan Y., Tang J., and Ju H. Disposable reagentless electrochemical immunosensor array based on a biopolymer/sol-gel membrane for simultaneous measurement of several tumor markers. Clin. Chem. 54 (2008) 1481-1488
28. Simberg D., Duza T., Park J.H., Essler M., Pilch J., Zhang L., Derfus A.M., Yang M., Hoffman R.M., Bhatia S., Sailor M.J., and Ruoslahti E. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 932-936
29. Javier D.J., Nitin N., Levy M., Ellington A., and Richards-Kortum R. Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging. Bioconjug. Chem. 19 (2008) 1309-1312
30. Farokhzad O.C., Jon S., Khademhosseini A., Tran T.N., Lavan D.A., and Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 64 (2004) 7668-7672
31. Berry C.C. Intracellular delivery of nanoparticles via the HIV-1 tat peptide. Nanomedicine 3 (2008) 357-365
32. Berry C.C., de la Fuente J.M., Mullin M., Chu S.W., and Curtis A.S. Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans. Nanobiosci. 6 (2007) 262-269
33. Field S.B., and Bleehen N.M. Hyperthermia in the treatment of cancer. Cancer Treat. Rev. 6 (1979) 63-94
34. Milleron R.S., and Bratton S.B. 'Heated' debates in apoptosis. Cell. Mol. Life Sci. 64 (2007) 2329-2333
35. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., and Schlag P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3 (2002) 487-497
36. Hildebrandt B., Wust P., Ahlers O., Dieing A., Sreenivasa G., Kerner T., Felix R., and Riess H. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43 (2002) 33-56
37. Curley S.A. Radiofrequency ablation of malignant liver tumors. Ann. Surg. Oncol. 10 (2003) 338-347
38. Ellis L.M., and Tanabe K.K. Radiofrequency ablation for cancer. Current Indication, Techniques, and Outcomes. 1st Ed (2004), Springer-Verlag, New York
39. Issels R.D. Hyperthermia adds to chemotherapy. Eur. J. Cancer 44 (2008) 2546-2554
40. Witkamp A.J., de Bree E., Van Goethem R., and Zoetmulder F.A. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat. Rev. 27 (2001) 365-374
41. Noorda E.M., Vrouenraets B.C., Nieweg O.E., van Coevorden F., van Slooten G.W., and Kroon B.B. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer 98 (2003) 1483-1490
42. Lienard D., Eggermont A.M., Kroon B.B., Schraffordt Koops H., and Lejeune F.J. Isolated limb perfusion in primary and recurrent melanoma: indications and results. Sem. Surg. Oncol. 14 (1998) 202-209
43. Bartlett D.L., Ma G., Alexander H.R., Libutti S.K., and Fraker D.L. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer 80 (1997) 2084-2090
44. van der Zee J., Gonzalez Gonzalez D., van Rhoon G.C., van Dijk J.D., van Putten W.L., and Hart A.A. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355 (2000) 1119-1125
45. Vernon C.C., Hand J.W., Field S.B., Machin D., Whaley J.B., van der Zee J., van Putten W.L., van Rhoon G.C., van Dijk J.D., Gonzalez Gonzalez D., Liu F.F., Goodman P., and Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int. J. Radiat. Oncol. Biol. Phys. 35 (1996) 731-744
46. Murakami R., Yoshimatsu S., Yamashita Y., Matsukawa T., Takahashi M., and Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR 164 (1995) 1159-1164
47. Curley S.A. Radiofrequency ablation of malignant liver tumors. Oncologist 6 (2001) 14-23
48. Lygidakis N.J., Sharma S.K., Papastratis P., Zivanovic V., Kefalourous H., Koshariya M., Lintzeris I., Porfiris T., and Koutsiouroumba D. Microwave ablation in locally advanced pancreatic carcinoma-a new look. Hepatogastroenterology 54 (2007) 1305-1310
49. Curley S.A., Izzo F., Ellis L.M., Nicolas Vauthey J., and Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg. 232 (2000) 381-391
50. Curley S.A., Marra P., Beaty K., Ellis L.M., Vauthey J.N., Abdalla E.K., Scaife C., Raut C., Wolff R., Choi H., Loyer E., Vallone P., Fiore F., Scordino F., De Rosa V., Orlando R., Pignata S., Daniele B., and Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann. Surg. 239 (2004) 450-458
51. Matlaga B.R., Zagoria R.J., Woodruff R.D., Torti F.M., and Hall M.C. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J. Urol. 168 (2002) 2401-2405
52. Jeffrey S.S., Birdwell R.L., Ikeda D.M., Daniel B.L., Nowels K.W., Dirbas F.M., and Griffey S.M. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch. Surg. 134 (1999) 1064-1068
53. Kalambur V.S., Longmire E.K., and Bischof J.C. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 23 (2007) 12,329-12,336
54. 4 nanoparticles: low toxicity and rapid heating for thermal therapy. J. Mat. Chem. 18 (2008) 1204-1208
55. Gobin A.M., Lee M.H., Halas N.J., James W.D., Drezek R.A., and West J.L. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 7 (2007) 1929-1934
56. Arnfield M.R., Mathew R.P., Tulip J., and McPhee M.S. Analysis of tissue optical coefficients using an approximate equation valid for comparable absorption and scattering. Phys. Med. Biol. 37 (1992) 1219-1230
57. Gannon C.J., Patra C.R., Bhattacharya R., Mukherjee P., and Curley S.A. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J. Nanobiotechnol. 6 (2008) 2
58. Curley S.A., Cherukuri P., Briggs K., et al. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J. Exp. Ther. Oncol. 7 (2008) 313-326
59. Kam N.W., O'Connell M., Wisdom J.A., and Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. 102 33 (2005) 11,600-11,605